Interestingly, modulation of Gal-1 expression during CeD development appeared to be specific as no differences were found in the expression of Gal-4, suggesting selective regulation of individual galectins during mucosal inflammation. The gene discussed is LGALS4; the disease is cranioectodermal dysplasia.